Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography

Annals of Neurology

Volumn 45, Issue 6, 1999, Pages 769-777

  Gilman, Sid ^a,c   Koeppe, Robert A ^a   Junck, Larry ^a   Little, Roderick ^b   Kluin, Karen J ^a,b   Heumann, Mary ^a   Martorello, Susan ^a   Johanns, Jewel ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROTETRABENAZINE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BINDING AFFINITY; BRAIN BLOOD FLOW; CONTROLLED STUDY; FEMALE; HEMISPHERE; HIGH RISK POPULATION; HUMAN; LIGAND BINDING; MALE; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SHY DRAGER SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; CORPUS STRIATUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; TETRABENAZINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032975059     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199906)45:6<769::AID-ANA11>3.0.CO;2-G     Document Type: Article

References (53)

1. Wenning GK, Ben Shlomo Y, Magalhães M, et al. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-845
2. Colosimo C, Albanese A, Hughes AJ, et al. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298
3. Wenning GK, Ben Shlomo Y, Magalhães M, et al. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166
4. Wenning GK, Tison F, BenShlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147
5. Fetoni V, Genitrini S, Monza D, et al. Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkinson's disease. Clin Neuropharmacol 1997; 20:239-244
6. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54:937-944
7. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997; 349:1877-1881
8. Smith GDP, Watson LP, Mathias CJ. Neurohumoral, peptidergic and biochemical responses to supine exercise in two groups with primary autonomie failure: Shy-Drager syndrome/multiple system atrophy and pure autonomie failure. Clin Autonom Res 1966;6:255-262
9. Smith GDP, Mathias CJ. Differences in cardiovascular responses to supine exercise and to standing after exercise in two clinical subgroups of Shy-Drager syndrome (multiple system atrophy). J Neurol Neurosurg Psychiatry 1996;61:297-303
10. Bonnet AM, Pichon J, Vidailhet, et al. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Mov Disord 1997;12:509-513
11. Gilman S, Quinn NP. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late onset cerebellar atrophy. Neurology 1996;46: 1197-1199
12. Gilman S, Koeppe RA, Junck L, et al. Patterns of cerebral glucose metabolism detected with PET differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994; 36:166-175
13. Otsuka M, Ichiya Y, Kuwabara Y, et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. J Neurol Sci 1996;144:77-83
14. Gilman S, Koeppe RA, Junck L, et al. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Ann Neurol 1995;38:176-185
15. Rinne JO, Burn DJ, Mathias CJ, et al. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar variant of multiple system atrophy. Ann Neurol 1995;37:568-573
16. Gilman S, Frey KA, Koeppe RA, et al. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Ann Neurol 1996;40:885-892
17. Churchyard A, Donnan GA, Hughes A, et al. Dopa resistance in multiple system atrophy: loss of postsynaptic D2 receptors. Ann Neurol 1993;34:219-226
18. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192
19. Shinotoh H, Inoue O, Hirayama K, et al. Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 1993;56:467-472
20. Gu M, Gash MT, Cooper JM et al. Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997; 12:418-422
21. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias C, eds. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 3rd ed. Oxford: Oxford University Press, 1992: 564-585
22. Oppenheimer DR, Esiri MM. Diseases of the basal ganglia, cerebellum and motor neurons. In: Hume Adams J, Duchen LW, eds. Greenfield's neuropathology. 5th ed. London: Edward Arnold, 1992:988-1045
23. Kume A, Takahashi A, Hashizume Y, Asai J. A histometrical and comparative study on Purkinje cell loss and olivary nucleus cell loss in multiple system atrophy. J Neurol Sci 1991;101: 178-186
24. Terao S, Sobue G, Hashizume Y, et al. Disease specific patterns of neuronal cell loss in the ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked bulbospinal neuronopathy, with special reference to loss of small neurons in the intermediate zone. J Neurol 1994;241:196-203
25. Ito H, Kusaka H, Matsumoto S, Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 1996;47:1291-1299
26. Papp MI, Khan JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100
27. Nakazato Y, Yamazaki H, Hirato J, et al. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990;49:521-530
28. Kato S, Nakamura H, Hirano A, et al. Argyrophilic ubiquinated cytoplasmic inclusions in Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy). Acta Neuropathol 1991;82:488-493
29. Mochizuki A, Mizusawa H, Ohkoshi N, et al. Argentophilic intracytoplasmic inclusions in multiple system atrophy. J Neurol 1992;239:311-316
30. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243
31. Kato S, Nakamura H. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol 1990;79:584-594
32. Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992;107:172-182
33. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57: 129-133
34. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243
35. Eadie MJ. Olivo-ponto-cerebellar atrophy (Dejerine-Thomas type). In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Amsterdam: North-Holland, 1975:415-431
36. Eadie MJ. Olivo-ponto-cerebellar atrophy (Menzel type). In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Amsterdam: North-Holland, 1975:433-449
37. Berciano J. Olivopontocerebellar atrophy: a review of 117 cases. J Neurol Sci 1982;53:253-272
38. Duvoisin RC. An apology and an introduction to the olivopontocerebellar atrophies. In: Duvoisin RC, Plaitakis A, eds. The olivopontocerebellar atrophies. New York: Raven Press, 1984: 5-12
39. Harding A. "Idiopathic" late onset cerebellar ataxia. In: Harding A, ed. The hereditary ataxias. Boston: Butterworths, 1984: 166-173
40. Koeppen AH, Baron KD. The neuropathology of olivopontocerebellar atrophy. In: Duvoisin RC, Plaitakis A, eds. The olivopontocerebellar atrophies. New York: Raven Press, 1984: 13-38
41. Koeppen AH. The Purkinje cell and its afferents in human hereditary ataxia. J Neuropathol Exp Neurol 1991;50:505-514
42. Ferrer I, Gens D, Dvalos A, et al. The Purkinje cell in olivopontocerebellar atrophy: a Golgi and immunocytochemical study. Neuropathol Appl Neurobiol 1994;20:38-46
43. 11C]DTBZ and PET. J Cereb Blood Flow Metab 1997; 17(Suppl 1):S694 (Abstract)
44. Frey KA, Koeppe RA, Kilbourn MR, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 1996;40:873-884
45. McLeod JG, Tuck RR. Disorders of the autonomic nervous system: part 2. Investigation and treatment. Ann Neurol 1987; 21:519-529
46. Consensus Committee of the American Autonomic Society and the American Academy of Neurology, 1996. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46:1470
47. Gilman S, Markel DS, Koeppe RA, et al. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol 1988;24: 223-230
48. Kluin KJ, Gilman S, Markel DS, et al. Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings. Ann Neurol 1988;23:547-554
49. Kluin KJ, Gilman S, Lohman M, Junck L. Characteristics of the dysarthria of multiple system atrophy. Arch Neurol 1996; 53:545-548
50. 11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab 1996;16:1288-1299
51. Bohnen NI, Meyer P, Albin RL, et al. Clinical correlates of striatal (+)-[C-11]DTBZ binding to VMAT2 in Parkinson's disease. J Nucl Med 1998;39(Suppl):15P
52. Gilman S. The mechanism of cerebellar hypotonia: an experimental study in the monkey. Brain 1969;92:621-638
53. Brooks DJ, Salmon EP, Mathias CJ, et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 1990;113:1539-1552